XORTX Therapeutics last closed at $1.70 (-0.83%) on 2026-10-05. Signals today: Mean reversion. Listed on Nasdaq. Trailing 12 months PER is -0.7×. Its overall grade ranks 714 of 741 stocks in Healthcare.
About this company
XORTX Therapeutics last closed at $1.70 (-0.83%) on 2026-10-05. Signals today: Mean reversion. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall F · 714/741
Valuation grade B-
Related stocks
- BioCryst PharmaceuticalsCompetitor
희귀질환·대사질환 중심의 소형 바이오로, XORTX의 통풍/요산질환 파이프라인과 경쟁 가능
- Uricase/urate-lowering drug developmentRelated theme
고요산혈증·통풍 치료제 개발 테마로 XORTX의 핵심 사업 영역
- Kidney disease therapeuticsRelated theme
만성 신장질환(CKD) 및 신장 보호 치료제 개발은 XORTX의 주요 적응증 테마
About XORTX Therapeutics
- What technical signals does XORTX Therapeutics (XRTX) have?
- XORTX Therapeutics current technical signals: Mean reversion.
- Is XORTX Therapeutics a cup-and-handle pattern?
- No. XORTX Therapeutics has no valid Cup signal right now.
- What published figures are available for XORTX Therapeutics?
- Trailing 12 months PER: -0.7×. Latest quarter PBR: 0.50×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-06 dataset
Turn what you saw on this name into a strategy
Ask Q about XORTX Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.